People

MannKind Corporation has announced the resignation of Hakan Edstrom, who was the company’s President and CEO, as well as a director. In the wake of the resignation, Alfred Mann has been appointed interim CEO, effective… Read more . . .

Hovione has announced that Kristine Senft has joined the company as VP, Sales and Marketing and will succeed Dave Hoffman as VP, Sales and Business Development upon his retirement in April 2016. Senft, who was… Read more . . .

Alexza Pharmaceuticals has promoted Catherine McAuliffe to VP, Operations and Stacy Palermini to VP, Finance, the company said. McAuliffe most recently served as Executive Director, Operations; the position of VP, Operations is newly created. Palermini… Read more . . .

Insys Therapeutics has announced that it will partner with Senzer Ltd, a subsidiary of Kind Consumer, to develop inhaled dronabinol (THC) and cannabidiol (CBD) products. Insys has licensed Senzer’s delivery technology, the same technology in… Read more . . .

Cirrus Pharmaceuticals announced that it has hired Andrew Hamer as VP R&D. Hamer was most recently Senior Director of R&D Operations at GSK’s dermatology subsidiary Stiefel. He also has experience in OINDP development at Cardinal,… Read more . . .

Intranasal analgesia developer Trigemina Inc. has announced the appointment of Shashidhar “Shashi” Kori as Chief Medical Officer. Trigemina’s TI-114 intranasal oxytocin, is in Phase 2 development for the treatment of migraine headaches; the company is… Read more . . .

Moerae Matrix, which is developing inhaled therapies for the treatment of idiopathic pulmonary fibrosis and other lung diseases, has announced the appointment of Bill Bradford as Chief Medical Officer. Bradford was most recently a Senior… Read more . . .

Current AstraZeneca Vice President Respiratory, Inflammation & Autoimmunity James Ward-Lilley will become CEO of Vectura Group as of October 1 2015. Vectura had previously announced that its current CEO, Chris Blackwell, will be stepping down… Read more . . .